» Articles » PMID: 15492044

Loss of Negative Regulation by Numb over Notch is Relevant to Human Breast Carcinogenesis

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 2004 Oct 20
PMID 15492044
Citations 223
Authors
Affiliations
Soon will be listed here.
Abstract

The biological antagonism between Notch and Numb controls the proliferative/differentiative balance in development and homeostasis. Although altered Notch signaling has been linked to human diseases, including cancer, evidence for a substantial involvement of Notch in human tumors has remained elusive. Here, we show that Numb-mediated control on Notch signaling is lost in approximately 50% of human mammary carcinomas, due to specific Numb ubiquitination and proteasomal degradation. Mechanistically, Numb operates as an oncosuppressor, as its ectopic expression in Numb-negative, but not in Numb-positive, tumor cells inhibits proliferation. Increased Notch signaling is observed in Numb-negative tumors, but reverts to basal levels after enforced expression of Numb. Conversely, Numb silencing increases Notch signaling in normal breast cells and in Numb-positive breast tumors. Finally, growth suppression of Numb-negative, but not Numb-positive, breast tumors can be achieved by pharmacological inhibition of Notch. Thus, the Numb/Notch biological antagonism is relevant to the homeostasis of the normal mammary parenchyma and its subversion contributes to human mammary carcinogenesis.

Citing Articles

Notch and Hedgehog Signaling Unveiled: Crosstalk, Roles, and Breakthroughs in Cancer Stem Cell Research.

Iluta S, Nistor M, Buruiana S, Dima D Life (Basel). 2025; 15(2).

PMID: 40003637 PMC: 11856057. DOI: 10.3390/life15020228.


NUMB alternative splicing and isoform-specific functions in development and disease.

Dho S, Othman K, Zhang Y, McGlade C J Biol Chem. 2025; 301(3):108215.

PMID: 39863103 PMC: 11889595. DOI: 10.1016/j.jbc.2025.108215.


Mechanisms of Regulation of Cell Fate in Breast Development and Cancer.

Van Keymeulen A Adv Exp Med Biol. 2025; 1464():167-184.

PMID: 39821026 DOI: 10.1007/978-3-031-70875-6_10.


Canonical and noncanonical NOTCH signaling in the nongenetic resistance of cancer: distinct and concerted control.

Huang X, Chen W, Wang Y, Shytikov D, Wang Y, Zhu W Front Med. 2025; 19(1):23-52.

PMID: 39745621 DOI: 10.1007/s11684-024-1107-1.


Loss of NUMB drives aggressive bladder cancer via a RHOA/ROCK/YAP signaling axis.

Tucci F, Pennisi R, Rigiracciolo D, Filippone M, Bonfanti R, Romeo F Nat Commun. 2024; 15(1):10378.

PMID: 39627202 PMC: 11615365. DOI: 10.1038/s41467-024-54246-6.


References
1.
Struhl G, Adachi A . Requirements for presenilin-dependent cleavage of notch and other transmembrane proteins. Mol Cell. 2000; 6(3):625-36. DOI: 10.1016/s1097-2765(00)00061-7. View

2.
Adams J, Palombella V, Sausville E, Johnson J, Destree A, Lazarus D . Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res. 1999; 59(11):2615-22. View

3.
Santolini E, Puri C, Salcini A, Gagliani M, Pelicci P, Tacchetti C . Numb is an endocytic protein. J Cell Biol. 2000; 151(6):1345-52. PMC: 2190585. DOI: 10.1083/jcb.151.6.1345. View

4.
Susini L, Passer B, Juven-Gershon T, Prieur S, Privat N, Tuynder M . Siah-1 binds and regulates the function of Numb. Proc Natl Acad Sci U S A. 2001; 98(26):15067-72. PMC: 64984. DOI: 10.1073/pnas.261571998. View

5.
Nie J, McGill M, Dermer M, Dho S, Wolting C, McGlade C . LNX functions as a RING type E3 ubiquitin ligase that targets the cell fate determinant Numb for ubiquitin-dependent degradation. EMBO J. 2002; 21(1-2):93-102. PMC: 125803. DOI: 10.1093/emboj/21.1.93. View